<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zhps</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал прикладной спектроскопии</journal-title><trans-title-group xml:lang="en"><trans-title>Zhurnal Prikladnoii Spektroskopii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0514-7506</issn><publisher><publisher-name>B. I. Stepanov Institute of Physics of the National Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">zhps-145</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BRIEF COMMUNICATIONS</subject></subj-group></article-categories><title-group><article-title>КОЛИЧЕСТВЕННЫЙ АНАЛИЗ ЛЕКАРСТВ С СИЛЬНО РАЗЛИЧАЮЩИМИСЯ КОНЦЕНТРАЦИЯМИ ФАРМАЦЕВТИЧЕСКИХ КОМПОНЕНТОВ С ПРИМЕНЕНИЕМ МЕТОДИК ВЫЧИТАНИЯ СПЕКТРОВ</article-title><trans-title-group xml:lang="en"><trans-title>QUANTITATIVE ANALYSIS OF DRUGS WITH HIGHLY DIFFERENT CONCENTRATIONS OF PHARMACEUTICAL COMPONENTS USING SPECTRAL SUBTRACTION TECHNIQUES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ayoub</surname><given-names>B. M.</given-names></name><name name-style="western" xml:lang="en"><surname>Ayoub</surname><given-names>B. M.</given-names></name></name-alternatives><email xlink:type="simple">bassam.ayoub@bue.edu.eg, drbassamchemistry@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Британский университет в Египте</institution></aff><aff xml:lang="en"><institution>British University in Egypt</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>10</day><month>03</month><year>2020</year></pub-date><volume>84</volume><issue>5</issue><fpage>830</fpage><lpage>833</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ayoub B.M., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Ayoub B.M.</copyright-holder><copyright-holder xml:lang="en">Ayoub B.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://zhps.ejournal.by/jour/article/view/145">https://zhps.ejournal.by/jour/article/view/145</self-uri><abstract><p>Разработаны два простых спектрофотометрических метода определения эмпаглифлозина и метформина путем манипулирования их относительными спектрами применительно к недавно одобренной фармацевтической комбинации - таблеткам Synjardy®. Для увеличения концентрации эмпаглифлозина после экстракции из таблеток с целью одновременного анализа с метформином использована методика дозируемых инъекций. Контрольные параметры соответствия требованиям Международной конференции по гармонизации, полученные для обоих препаратов с помощью методов постоянного умножения и вычитания спектров, приемлемы в диапазоне концентраций 2-12 мкг/мл. Предложенные оптимизированные методы могут быть использованы в лабораториях контроля качества. </p></abstract><trans-abstract xml:lang="en"><p>Two simple spectrophotometric methods were developed for determination of empagliflozin and metformin by manipulating their ratio spectra with application on a recently approved pharmaceutical combination, Synjardy® tablets. A spiking technique was used to increase the concentration of empagliflozin after extraction from the tablets to allow its simultaneous determination with metformin. Validation parameters according to ICH guidelines were acceptable over the concentration range of 2-12 μg/mL for both drugs using constant multiplication and spectrum subtraction methods. The optimized methods are suitable for QC labs.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дозируемая инъекция</kwd><kwd>постоянное умножение</kwd><kwd>вычитание спектра</kwd><kwd>эмпаглифлозин</kwd><kwd>метформин</kwd><kwd>spiking</kwd><kwd>constant multiplication</kwd><kwd>spectrum subtraction</kwd><kwd>empagliflozin</kwd><kwd>metformin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">L. Merker, H. U. Haring, A. V. Christiansen, F. Roux, A. Salsali, G. Kim, T. Meinicke, H. J. Woerle, U. C. Broedl, Diabet. Med., 32, 1555-1567 (2015).</mixed-citation><mixed-citation xml:lang="en">L. Merker, H. U. Haring, A. V. Christiansen, F. Roux, A. Salsali, G. Kim, T. Meinicke, H. J. Woerle, U. C. Broedl, Diabet. Med., 32, 1555-1567 (2015).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">B. M. Ayoub, RSC Adv., 5, 95703-95709 (2015).</mixed-citation><mixed-citation xml:lang="en">B. M. Ayoub, RSC Adv., 5, 95703-95709 (2015).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">B. M. Ayoub, Spectrochim. Acta: Mol. Biomol. Spectrosc., 168, 118-122 (2016).</mixed-citation><mixed-citation xml:lang="en">B. M. Ayoub, Spectrochim. Acta: Mol. Biomol. Spectrosc., 168, 118-122 (2016).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">B. M. Ayoub, Der Pharma Chem., 8, 23-29 (2016).</mixed-citation><mixed-citation xml:lang="en">B. M. Ayoub, Der Pharma Chem., 8, 23-29 (2016).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Y. M. Fayez, Spectrochim. Acta: Mol. Biomol. Spectrosc., 132, 446-451 (2014).</mixed-citation><mixed-citation xml:lang="en">Y. M. Fayez, Spectrochim. Acta: Mol. Biomol. Spectrosc., 132, 446-451 (2014).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Note for guidance on validation of analytical procedures: Methodology (ICH harmonized tripartite guideline Q2B), Pharm. Ind., 59, 107-110 (1997).</mixed-citation><mixed-citation xml:lang="en">Note for guidance on validation of analytical procedures: Methodology (ICH harmonized tripartite guideline Q2B), Pharm. Ind., 59, 107-110 (1997).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
